Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis

To minimize the clinical burden associated with multiple sclerosis (MS), early control of focal and diffuse CNS disease activity is a treatment priority. A post hoc analysis was conducted to evaluate the onset of efficacy of fingolimod treatment in patients with relapsing MS. Data from patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappos, Ludwig, Radue, Ernst-Wilhelm, Chin, Peter, Ritter, Shannon, Tomic, Davorka, Lublin, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751181/
https://www.ncbi.nlm.nih.gov/pubmed/26645392
http://dx.doi.org/10.1007/s00415-015-7978-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751181/
https://www.ncbi.nlm.nih.gov/pubmed/26645392
http://dx.doi.org/10.1007/s00415-015-7978-y

Ejemplares similares